AzTrials
AzTrials

ObesityNCT03990350

Gut Microbiota Composition in Hispanic and Non-Hispanic Children.

An observational study of Obesity, run by Nemours Children's Clinic at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The human gastrointestinal (GI) tract is filled with millions of bacteria that can affect our health. These bacteria are linked with our overall health including obesity risk. In the United States the Hispanic population is one of the ethnic groups at higher risk of developing obesity. Read more about this study

Who is it for?
Ages 6 to 12 yearsHealthy volunteers can take part
Conditions the study is for
Obesity
What is being tested?
Fecal Sample Collection, Physical Activity Questionnaire and Food Frequency Questionnaire
How many people
17 participants
Where
1 siteUnited States
Study dates
14 Jun 2019to 15 Jun 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 12 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: The investigators will recruit and enroll 4 cohorts including 6 Hispanic children with obesity, 6 Hispanic children without obesity, 6 Caucasian non-Hispanic children with obesity and 6 Caucasian non-Hispanic children without obesity. Obesity will be defined as a BMI >95%. Enrollment age will be between 6-12 years of age.

Who may be able to join

  • Caucasian non-Hispanic and Hispanic Children with and without obesity.

Who cannot join

  • if the subject has a current or recent (within the past 14 days) gastrointestinal infection (viral, bacterial, or fungal)
  • Known to have gastrointestinal mucosal disease or have clinically significant constipation.
  • Children taking probiotics.
  • History of antibiotic use within the last 6 months at the time of recruitment.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Nemours/AI duPont Hospital for Children

    Wilmington, Delaware, 19803

Other trials in United States

About this study

Official title: Comparison of the Gut Microbiota Composition in Caucasian Hispanic and Caucasian Non-Hispanic Children With and Without Obesity

The human gastrointestinal (GI) tract is filled with millions of bacteria that can affect our health. These bacteria are linked with our overall health including obesity risk. In the United States the Hispanic population is one of the ethnic groups at higher risk of developing obesity. In this study the team will investigate differences in the GI bacterial composition between Hispanic and Caucasian children, and potentially demonstrate a correlation between the composition of metagenome and a higher risk to develop obesity. This will be done by collecting stool samples and comparing the bacteria found in the stool of Hispanic children (with and without obesity) and Caucasian children (with and without obesity.

Read the detailed description
  1. SPECIFIC AIMS There are a vast number of microbes in the human gastrointestinal tract (GI) including bacterial, fungal and protozoal microorganisms which all together make our microbiome. Over the last years evidence has shown that the GI microbiome is linked with our overall health including obesity risk. The GI microbiota can influence both sides of the energy balance that includes factors influencing energy utilization from the diet and factors that play a role in the regulation of energy expenditure and storage by influencing host genes (1, 2). Studies of demonstrated that overweight and obesity rates are among the highest for Hispanic children in the United States. It is estimated that in the US 47% of Hispanic children are overweight and 31% have obesity, compared to 35% and 21% respectively for Caucasian non-Hispanic children. Literature has shown environment factors are associated with childhood obesity in Hispanic children including: parental influences, screen time, physical activity behavior, socioeconomic status/food security, and sleep duration (3,4). Thus far there have been no studies having investigated if there are significant differences in the gut microbiome of Hispanic children; moreover, whether these differences (taxonomy or gene expression) puts them at higher risk to develop obesity compared other ethnic groups.

The investigators predict there are significant GI microbiome differences between Caucasian non-Hispanic children and Hispanic Children.

Aim: Confirm differences in microbiome between Caucasian non-Hispanic children (with and without obesity) and Hispanic children (with and without obesity) in this pilot study.

Hypothesis: Hispanic children will have a lower fecal bacterial diversity compared to Caucasian non-Hispanic children that is associated with more overall adiposity and impaired glucose homeostasis determined by:

  1. Next generation metagenomic "whole genome/shotgun" sequencing of DNA from fecal samples of cohorts which includes Hispanic children with obesity, Hispanic children without obesity, Caucasian non-Hispanic children with obesity and Caucasian non-Hispanic children without obesity.
  2. Bioinformatics computational analysis comparing the four groups to determine beta diversity (relative taxonomic) abundance.

II. BACKGROUND AND SIGNIFICANCE Obesity is a serious health risk in the United States. The prevalence of childhood obesity has increased over the last two decades. According the U.S. Department of health and Human Services, recent date showed that the prevalence of obesity higher among youth aged 6-11 year and adolescents aged 12-19 years compared with children aged 2-5 years of age. The Hispanic population is among the most affected ethnic groups in the United States. Approximately 47% of Hispanic children are overweight and 31% have obesity. Multiple factors have been found to play a role in the development of childhood obesity in Hispanic children, including: parental influences, screen time, physical activity behavior, socioeconomic status/food security, and sleep duration.

Over the last few years there has been a research interest in understanding the development and pathogenesis of obesity. Recent studies have found that the gut microbiota plays in an important role in the triggering and the development on obesity. The GI microbiota can influence both sides of the energy balance that includes factors influencing energy utilization from the diet and factors that play a role in the regulation of energy expenditure and storage by influencing host genes. In a study by Hou, they evaluated the 16S rRNA gene, the enterotypes and quantity of gut microbiota among obese children and a healthy control cohort. In this study they found that the composition of the gut microbiota showed significant differences between obese children and healthy controls. The results indicated that the phyla of Firmicutes and Bacteroidetes were the predominant fecal microbiome in both cohorts but the relative abundance ratio of Firmicutes and Bacteroidetes (F/B) in the obese cohort was significantly higher than that in the healthy controls. Firmicutes are associated with genes involved in carbohydrate catabolism and is rich in obese individuals, while Bacteroidetes are linked with diminished body mass.

At this time there have been no studies that have investigated if there are significant differences in the gut microbiome of Hispanic children; moreover, whether these differences (taxonomy or gene expression) puts them at higher risk to develop obesity compared other ethnic groups. The study team feels it is important to identify possible microbiome differences in the Hispanic population that may put them at a higher risk of developing childhood obesity.

III. RESEARCH DESIGN AND METHODS INCLUDING STATISTICAL ANALYSIS Study Subjects/Experimental Design The investigators will recruit and enroll 4 cohorts including 6 Hispanic children with obesity, 6 Hispanic children without obesity, 6 Caucasian non-Hispanic children with obesity and 6 Caucasian non-Hispanic children without obesity. Obesity will be defined as a BMI >95%. Enrollment age will be between 6-12 years of age. The investigators will obtain baseline characteristics at the time of enrollment, including anthropometric measures (weight, length, BMI), dietary history (including 24 hour recall diary and a food frequency questionnaire), and physical activity history (Physical activity questionnaire). The investigators will obtain medication history, including history of use antibiotics, steroids and probiotics.

Dietary and Physical activity measurement At fecal collection, investigators will obtain dietary information for the patient using a 30-food item food frequency questionnaire and a 24-hour food recall diary. Diet records will be analyzed using the Nutrient Data System for Research software (Minneapolis, MN). The investigators will determine intake of macro- and micronutrient intake as well as patterns of dietary intake using the latent class (person-centered approach) as well as factor (data-based approach) analyses.

The investigators will collect physical activity data on the patient using the Physical Activity Questionnaire for Older Children (PAQ-C) and will analyze with Spearman correlation coefficients. Clinical data management will be the responsibility of the principal investigator and GI fellow/co-investigator and will use a secure database, REDCap, through Nemours' REDCap system.

Fecal Sample Collection With permission from the parent/guardian, stool collected in a sterile container will be brought within 12 hours of defecation from home or the outpatient clinic to a separate clinical laboratory where feces will be collected through use of FLOQswab brush x 3 (Copan Diagnostics, Murrieta, CA) The swabs will be pre-labeled with a de-identified code reflecting patient number, sample number, and date and the sample will be placed into dry ice then transferred to a -80 degrees Celsius freezer until retrieval by the research staff for transfer to CHOP Microbiome Center.

Bacterial DNA Isolation DNA will be extracted from samples using the DNeasy PowerSoil kit using the manufacturer's instructions (Qiagen, Germantown, MD). Shotgun libraries will be generated from 1 ng of DNA using the NexteraXT kit (Illumina, San Diego, CA, USA). Libraries will be sequenced on an Illumina HiSeq 2500 using 2x125bp chemistry in High Output mode.

Bioinformatics processing and statistical analysis Differences in weight gain, HgbA1c, physical activity associated with nutritional diet records or other outcomes will be assessed using t-test or Mann Whitney U test, adjusting for covariates. The relationship between nutrition records and outcomes will be further examined using mixed effects models, adjusting for the effect of key physical activity or dietary variables.

FASTQ files will be analyzed using an established computational pipeline developed at Nemours.

Conditions
Obesity
Being tested
Fecal Sample Collection, Physical Activity Questionnaire, Food Frequency Questionnaire, 24-hour dietary recall diary
Keywords
Gut Microbiome
Medical subject headings
Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Fecal Sample CollectionOther

    With permission from the parent/guardian, stool collected in a sterile container will be brought within 12 hours of defecation from home or the outpatient clinic to a separate clinical laboratory where feces will be collected through use of FLOQswab brush x 3 (Copan Diagnostics, Murrieta, CA) The swabs will be pre-labeled with a de-identified code reflecting patient number, sample number, and date and the sample will be placed into dry ice then transferred to a -80 degrees Celsius freezer until retrieval by the research staff for transfer to CHOP Microbiome Center.

  • Physical Activity QuestionnaireOther

    At the initial encounter the co-investigator Dr. David Garcia, who is a certified Spanish translator will complete the Physical Activity Questionnaire (Physical Activity Questionnaire for Older Children) with the subject and parent.

  • Food Frequency QuestionnaireOther

    At the initial encounter the co-investigator Dr. David Garcia, who is a certified Spanish translator will complete the Food Frequency Questionnaire with the subject and parent.

  • 24-hour dietary recall diaryOther

    At the initial encounter the co-investigator Dr. David Garcia, who is a certified Spanish translator will complete the 24-hour dietary recall diary with the subject and parent.

Study groups in NCT03990350
Study groupRoleWhat they receive
Hispanic children with obesityNot described
Receives: Other: Fecal Sample Collection; Other: Physical Activity Questionnaire; Other: Food Frequency Questionnaire; Other: 24-hour dietary recall diary
Hispanic children without obesityNot described
Receives: Other: Fecal Sample Collection; Other: Physical Activity Questionnaire; Other: Food Frequency Questionnaire; Other: 24-hour dietary recall diary
Caucasian non-Hispanic children with obesityNot described
Receives: Other: Fecal Sample Collection; Other: Physical Activity Questionnaire; Other: Food Frequency Questionnaire; Other: 24-hour dietary recall diary
Caucasian non-Hispanic children without obesityNot described
Receives: Other: Fecal Sample Collection; Other: Physical Activity Questionnaire; Other: Food Frequency Questionnaire; Other: 24-hour dietary recall diary

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Metagenome of each patient's fecal sample

    sequence of all bacterial DNA and other organism's DNA in a sample

    Measured: through study completion, an average of 9 months

  2. Physical Activity

    Administer a validated physical activity questionnaire

    Measured: through study completion, an average of 9 months

  3. Food frequency questionnaire

    Administer a validated food frequency questionnaire

    Measured: through study completion, an average of 9 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jun 2019
  2. Study start14 Jun 2019
  3. Primary completion28 Feb 2020
  4. Study completion15 Jun 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
17 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03990350
Sponsor's protocol ID
1347478
Status last verified
Jun 2020
First submitted
16 May 2019
Last updated
30 Jun 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Davis CD. The Gut Microbiome and Its Role in Obesity. Nutr Today. 2016 Jul-Aug;51(4):167-174. doi: 10.1097/NT.0000000000000167.

    PubMed 27795585
  • Carrera-Quintanar L, Ortuno-Sahagun D, Franco-Arroyo NN, Viveros-Paredes JM, Zepeda-Morales AS, Lopez-Roa RI. The Human Microbiota and Obesity: A Literature Systematic Review of In Vivo Models and Technical Approaches. Int J Mol Sci. 2018 Nov 30;19(12):3827. doi: 10.3390/ijms19123827.

    PubMed 30513674
  • Ochoa A, Berge JM. Home Environmental Influences on Childhood Obesity in the Latino Population: A Decade Review of Literature. J Immigr Minor Health. 2017 Apr;19(2):430-447. doi: 10.1007/s10903-016-0539-3.

    PubMed 28005241
  • Lindsay AC, Wallington SF, Lees FD, Greaney ML. Exploring How the Home Environment Influences Eating and Physical Activity Habits of Low-Income, Latino Children of Predominantly Immigrant Families: A Qualitative Study. Int J Environ Res Public Health. 2018 May 14;15(5):978. doi: 10.3390/ijerph15050978.

    PubMed 29757941
  • Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of Obesity Among Adults and Youth: United States, 2015-2016. NCHS Data Brief. 2017 Oct;(288):1-8.

    PubMed 29155689
  • Del Chierico F, Abbatini F, Russo A, Quagliariello A, Reddel S, Capoccia D, Caccamo R, Ginanni Corradini S, Nobili V, De Peppo F, Dallapiccola B, Leonetti F, Silecchia G, Putignani L. Gut Microbiota Markers in Obese Adolescent and Adult Patients: Age-Dependent Differential Patterns. Front Microbiol. 2018 Jun 5;9:1210. doi: 10.3389/fmicb.2018.01210. eCollection 2018.

    PubMed 29922272
  • Hou YP, He QQ, Ouyang HM, Peng HS, Wang Q, Li J, Lv XF, Zheng YN, Li SC, Liu HL, Yin AH. Human Gut Microbiota Associated with Obesity in Chinese Children and Adolescents. Biomed Res Int. 2017;2017:7585989. doi: 10.1155/2017/7585989. Epub 2017 Oct 29.

    PubMed 29214176
  • Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014 Aug 1;30(15):2114-20. doi: 10.1093/bioinformatics/btu170. Epub 2014 Apr 1.

    PubMed 24695404
  • Wood DE, Salzberg SL. Kraken: ultrafast metagenomic sequence classification using exact alignments. Genome Biol. 2014 Mar 3;15(3):R46. doi: 10.1186/gb-2014-15-3-r46.

    PubMed 24580807
  • Pereira MB, Wallroth M, Jonsson V, Kristiansson E. Comparison of normalization methods for the analysis of metagenomic gene abundance data. BMC Genomics. 2018 Apr 20;19(1):274. doi: 10.1186/s12864-018-4637-6.

    PubMed 29678163
  • Li D, Liu CM, Luo R, Sadakane K, Lam TW. MEGAHIT: an ultra-fast single-node solution for large and complex metagenomics assembly via succinct de Bruijn graph. Bioinformatics. 2015 May 15;31(10):1674-6. doi: 10.1093/bioinformatics/btv033. Epub 2015 Jan 20.

    PubMed 25609793
  • Hyatt D, LoCascio PF, Hauser LJ, Uberbacher EC. Gene and translation initiation site prediction in metagenomic sequences. Bioinformatics. 2012 Sep 1;28(17):2223-30. doi: 10.1093/bioinformatics/bts429. Epub 2012 Jul 12.

    PubMed 22796954
  • Tatusov RL, Koonin EV, Lipman DJ. A genomic perspective on protein families. Science. 1997 Oct 24;278(5338):631-7. doi: 10.1126/science.278.5338.631.

    PubMed 9381173
  • Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013 Jan 1;29(1):15-21. doi: 10.1093/bioinformatics/bts635. Epub 2012 Oct 25.

    PubMed 23104886
  • Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 2011 Aug 4;12:323. doi: 10.1186/1471-2105-12-323.

    PubMed 21816040

Questions about this trial

What is this clinical trial studying?

An observational study of Obesity, run by Nemours Children's Clinic at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Jun 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Metagenome of each patient's fecal sample (time frame: through study completion, an average of 9 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03990350, which also lists 16 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jun 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT03990350 | AzTrials